Skip to main content

Google Translate Widget by Infofru

Author Site Reviewresults

ICTriplex

Dr. Philip A. Salem is the innovator of the cancer treatment breakthrough consisting of a concomitant combination of personalized Immunotherapy, Chemotherapy, and Targeted therapy (‘ICTriplex Treatment’).

Although the medications he administers in this treatment are individually FDA-approved, the overall concomitant therapy protocol is not. Patients who have been treated using ICTriplex have experienced more than 95% response rate, particularly in lung and pancreatic cancers.

Dr. Salem hopes that this treatment will be more widely available to those outside his clinic in the coming years, and he is working to educate the next generation of oncologists on this groundbreaking treatment in cancer medicine. To learn more, watch the videos below:

Additional Reading

ASCO Abstract 2019
Read more
ASCO Abstract 2020
Read more
ASCO Abstract 2022
Read more
ASCO Abstract Breakthrough 2024
Read more
Trends in Cancer Research Manuscript 2020
Read more
The Lebanese Doctor in Diaspora
Read more